-

Why Hypoparathyroidism May Be the Best First Market for Biofabricated Endocrine Tissue Therapeutics
A small, retrievable, vascularized parathyroid micro-organ built from iPSC-derived endocrine cells could prove the broader biofabricated endocrine tissue thesis — restoring calcium-responsive PTH physiology rather than chronically dosing hormone replacement.






